Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Sublingual nicotine tablets as alternative to Nicorette gum: clinical results reported at FIP '99

Sep. 8, 1999

Ferriprox approved in Europe as second-line thalassemia therapy

Aug. 27, 1999

Advances in the immunotherapy of cocaine abuse at Scripps Research Institute

Aug. 26, 1999

Academic researchers identify MAb as effective treatment for PCP addiction

Aug. 25, 1999

New treatments for alcoholism reported by Lipha

Aug. 23, 1999

Pfizer reveals new series of nicotinic acetylcholine receptor-modulating agents

Aug. 17, 1999

Therapeutic Antibodies submits PLA and ELA for DigiTAb

Aug. 12, 1999

BP-897, a partial dopamine D3 receptor agonist with potential in treating cocaine dependency

Aug. 2, 1999

Lilly designs selective 5-HT1A antagonists especially for nicotine/tobacco withdrawal

July 12, 1999

LecTec granted patents on cotinine for smoking cessation and psychiatric disorders

July 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...